The egg recall that pulled nearly 20 million eggs from store shelves and commercial kitchens has just been escalated to the most serious category on the FDA's risk scale — and for investors in egg producers, the timing could hardly be worse. On August 12, 2026, the U.S. Food and Drug Administration reclassified the salmonella-linked recall of eggs from Midwest Poultry Services, L.P. as a Class I recall, the agency's highest severity level. That designation is reserved for situations where there is "a reasonable probability" that exposure to a product "will cause serious adverse health consequences or death."
The upgrade lands squarely on a sector already struggling to digest collapsing egg prices, a multi-million-dollar antitrust settlement with the Justice Department, and producer margins squeezed by rising feed, fuel, and labor costs. For shareholders of the biggest publicly traded egg companies — led by Cal-Maine Foods (NASDAQ: CALM) — the recall is the latest headline in a story that has turned one of 2025's hottest trades into one of 2026's most closely watched risk events.
Inside the Class I Egg Recall: What Was Pulled and Where
The recall traces back to two Texas farms operated by Midwest Poultry Services, L.P., a privately held producer that announced the voluntary recall on July 22, 2026. In total, the company pulled 1,589,577 dozen shell eggs — more than 19 million individual eggs — sold in bulk and retail cartons of 6, 12, 18, 24, 30, 36, and 60 eggs, according to the Centers for Disease Control and Prevention.
Timeline: From Two Texas Farms to a National Warning
The outbreak's progression from routine recall to top-tier safety alert unfolded over roughly three weeks:
- June 6–July 3, 2026: Recalled eggs are produced and distributed from two Texas farms.
- July 22, 2026: Midwest Poultry Services recalls 1,589,577 dozen shell eggs over possible Salmonella Enteritidis contamination, citing its own proactive environmental monitoring and root-cause analysis.
- July 24, 2026: The FDA and CDC open a joint multistate outbreak investigation and issue a public advisory to stop selling and serving the eggs.
- August 12, 2026: The FDA upgrades the recall to Class I, its highest risk category, signaling a "reasonable probability" of serious health consequences or death.
- August 14–15, 2026: National outlets, including The New York Times, USA Today, and Time, report the escalation as cases mount.
Why the Egg Recall Hits an Already-Bruised Sector
For investors, the recall is more than a food-safety headline — it lands in the middle of a brutal repricing of the egg business. A year ago, avian flu had decimated the nation's laying flocks, pushing egg prices to record highs and sending shares of producers soaring. That dynamic has since reversed dramatically.
By March 2026, egg prices had tumbled roughly 42% from the prior year as flocks recovered, according to NPR. By May, analysts were warning of oversupply, with CNBC reporting that producers faced a margin squeeze from persistent feed, fuel, and labor costs even as prices fell. The pain shows up clearly in the numbers: Cal-Maine Foods, the largest egg producer in the U.S., reported fourth-quarter fiscal 2026 net sales of $552.6 million — down 49.9% from $1.1 billion in the same quarter a year earlier.
Then came the legal blow. In late June 2026, the Justice Department and 17 states reached settlements with Cal-Maine, Versova, and Hickman's Egg Ranch over allegations that the producers illegally colluded for years to raise egg prices. The three companies agreed to pay $3.3 million and donate 53 million eggs to food banks, with Cal-Maine alone contributing $1.5 million and 30 million eggs while denying wrongdoing.
Into that mix, a Class I salmonella recall adds a fresh layer of reputational and operational risk. Although Midwest Poultry Services is a separate, privately held company, the presence of the "Cal-Maine" brand name on some recalled cartons — as listed by the CDC — has drawn renewed scrutiny to the industry's biggest public player. Any perception that the sector's safety or pricing practices have weakened can weigh on sentiment, even when a recall's direct financial impact is limited to one producer.
Where the Salmonella Outbreak Stands Now
The human toll so far has been significant but contained. The CDC reports 98 confirmed illnesses and 26 hospitalizations across 17 states, with zero deaths as of mid-August. Salmonella Enteritidis typically causes diarrhea, fever, and stomach cramps, with young children, adults 65 and older, and people with weakened immune systems most at risk of severe illness.
Critically, the FDA has said Midwest Poultry Services "does not account for all the illnesses in this outbreak" and that additional investigation is ongoing to identify other possible sources. That caveat keeps the door open for a wider recall or additional producer involvement — an uncertainty investors will be watching closely. The agency has also urged anyone holding affected cartons to throw them out or return them for a full refund.
What's Next for Egg Producers and Their Investors
Looking ahead, the near-term path for egg stocks hinges on three questions: whether the investigation expands beyond Midwest Poultry Services, how quickly oversupply and soft pricing normalize, and whether the antitrust settlements mark the end of legal scrutiny or the beginning of further regulatory pressure on the industry.
For now, the Class I designation is a reminder that even a staple food category carries binary, headline-driven risk. Investors weighing egg producers should watch for updated CDC case counts, any expansion of the recall, and the sector's next quarterly earnings for signs of how the price collapse is flowing through margins.
Key Takeaways from the Class I Egg Recall
- The FDA upgraded the Midwest Poultry Services egg recall to Class I on August 12, 2026, covering more than 19 million eggs.
- The salmonella outbreak has caused 98 illnesses and 26 hospitalizations across 17 states, with no deaths reported.
- Recalled brands include Kroger, Simple Truth, Brookshire's, and Country Morning, with the CDC also listing "Cal-Maine" on some cartons.
- The recall compounds sector pressure: egg prices are down roughly 42% year over year and Cal-Maine's Q4 net sales fell 49.9%.
- The FDA says the producer doesn't account for all illnesses, leaving the door open to a wider investigation.
